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Resumo 
CONTEXTO: As queixas laringofaríngeas são frequentes no pós-operatório 
após abordagem da via aérea. 
OBJETIVO: No nosso estudo pretendemos comparar a incidência de dor de 
garganta, disfonia, disfagia e lesões traumáticas dos tecidos moles entre os 
pacientes submetidos a entubação orotraqueal e máscara laríngea. 
TIPO DE ESTUDO: Estudo prospectivo observacional. 
LOCAL: Num único centro hospitalar entre Setembro de 2011 e Dezembro de 
2011. 
PARTICIPANTES: Foram avaliados 48 pacientes de ambos os sexos (idade 
compreendida entre 19-85 anos), que foram submetidos a cirurgia electiva sob 
anestesia geral. Critérios de exclusão foram: idade inferior a 18 anos, história 
recente de dor de garganta, cirurgias da cabeça e pescoço, disfonia pré-
operatória e cirurgia de emergência. 
INTERVENÇÃO: Avaliamos 48 pacientes: 26 foram submetidos a entubação 
orotraqueal (54%) e em 22 foi usada a máscara laríngea (46%). A seleção da 
técnica de abordagem da via aérea ficou à responsabilidade do 
anestesiologista que era cego para o estudo. Foi seguido o protocolo hospitalar 
para controlo da dor pós-operatória. 
MEDIDAS PRINCIPAIS: No recobro, 4h a 24h depois da cirurgia os pacientes 
foram questionados sobre a presença de dor de garganta, disfonia e disfagia. A 
boca foi inspeccionada para avaliação de lesões nos lábios, língua e úvula. 
RESULTADOS: Após entubação orotraqueal 46% dos doentes queixaram-se 
de disfonia assim como 50% dos doentes referiram o mesmo sintoma após a 
utilização de máscara laríngea (p=0.79). A disfagia foi mais frequente após 
entubação orotraqueal comparativamente à inserção da máscara laríngea 
(15,4% vs 9%, p=0.67). Relativamente à dor de garganta foi relatada por 31% 
dos pacientes do grupo de entubação orotraqueal, enquanto que 14% do grupo 
de máscara laríngea referiu este sintoma (p=0.29). 
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CONCLUSÃO: A disfonia após o uso da máscara laríngea é mais frequente 
que a reportada em estudos anteriores. As duas técnicas de abordagem da via 
aérea, máscara laríngea e tubo orotraqueal, são semelhantes nas variáveis 
estudadas. 
 
 
 
Palavras-Chave: Máscara laríngea; Entubação orotraqueal; Laringoscopia; 
Anestesia geral; Dor de garganta; Disfonia; Disfagia; Trauma de tecidos moles. 
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Abstract 
 
CONTEXT: Postoperative laryngo-pharyngeal complaints are common following 
airway management of patients. 
OBJECTIVE: In this study we compare the incidence of sore throat, dysphonia, 
dysphagia and soft tissue trauma between patients underwent endotracheal 
tube and laryngeal mask airway. 
DESIGN: This was a prospective observational study. 
SETTING: In a single university between September 2011 and December 2011. 
PATIENTS OR OTHER PARTICIPANTS: 48 patients evaluated, both genders 
(aged 19-85 years) who were submitted to elective surgery under anesthesia 
general. Exclusion criteria were: age under 18 years old, recent history of sore 
throat, head and neck surgeries, preoperative dysphonia and emergency 
surgery. 
INTERVENTION: We evaluated 48 patients: 26 underwent endotracheal tube 
(54%) and 22 laryngeal mask airway (46%). Selection of the airway technique 
was up to the anesthesiologist’s choice that was blind for this study. 
Postoperative analgesic management followed hospital protocol. 
MAIN OUTCOME MEASURES: In the recovery room, 4h to 24h after the 
surgery the patients were asked about the existence of sore throat, dysphonia 
and dysphagia. The mouth was inspected for any damage in the lips, tongue 
and uvula. 
RESULTS: Dysphonia was felt in 46% of the patients after endotracheal tube 
and 50% after laryngeal mask airway patients (p=0.79). Dysphagia was higher 
following endotracheal tube compared with laryngeal mask airway insertion 
(15,4% vs 9%, p=0.67). Sore throat was reported by 31% of patients in the 
endotracheal tube group and 14% of the laryngeal mask airway group (p=0.29). 
6 
 
CONCLUSIONS: Dysphonia following laryngeal mask airway seems to be more 
frequent than previously reported in other studies. Both airway devices, 
laryngeal mask airway and endotracheal tube, are similar in the studied 
variables. 
 
 
Keywords: Laryngeal mask airway; Endotracheal tube; Laryngoscope; 
Anaesthesia general; Sore throat; Dysphonia; Dysphagia; Soft tissue trauma. 
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Introduction 
 
Laryngeal Mask Airway (LMA) is a well-established alternative airway access to 
endotracheal tube (ETT) for elective surgical procedures and it can be inserted 
without the aid of a laryngoscope or neuromuscular blockade. 
Postoperative airway complications such as sore throat, dysphonia and 
dysphagia (discomfort in swallowing) are common complaints following either 
ETT or LMA.(1) Bilateral vocal cord palsy is a possible complication associated 
with the use of LMA.(2) 
In this prospective clinical study we compared the incidence and severity of 
sore throat (constant pain), dysphonia and dysphagia from LMA or ETT. The 
severity of all symptoms was assessed on a 10 point numerical rating scale. In 
our study, a standardized questionnaire with direct questions was used. 
Previous studies have associated endotracheal intubation with a greater 
incidence of sore throat and dysphonia than LMA with complaints limited in their 
intensity and duration.(3-5) The incidence of sore throat due to LMA varies 
between 5.8-34%, and after ETT between 14.4-50% in another study.(6)  This 
difference is presumably due to different techniques and different skillset of the 
performing anesthesiologists and will also change depending on different types 
of questionnaires. It is well recognized that the method of questioning is an 
important determinant of the incidence of sore throat, with incidence varying if 
this symptom is asked about directly or indirectly.(4, 6, 7) 
The LMA does not transverse the vocal cords and therefore, the incidence of 
dysphonia is less than that induced by ETT.(8) In some cases, there is a direct 
contact of the LMA with the vocal chords and the arytenoid cartilage, leading 
LMA to induce dysphonia.(8) LMA associated dysphonia can also arise from the 
inhalation of cold and dry inspiratory gases passing through the vocal chords 
and from the air flow during positive pressure ventilation which can cause 
involuntary vibration thus irritating the unparalyzed vocal chords possibly 
leading to postoperative dysphonia.(5, 9) 
8 
 
When evaluating dysphagia, the incidence is 23.8% with LMA and 12.5% in 
ETT.(5) In our literature review, dysphonia is lower with LMA 0-25.3% 
compared to ETT which varies between 25-46.8%. (5, 10, 11) 
Several studies have identified numerous risk factors related with impaired 
laryngeal mobility following ETT such as endotracheal size, cuff pressure, use 
of N2O (diffuses through the tube’s cuff), demographic factors (women), 
duration of anaesthesia, type of surgery and quality of tracheal intubation.(12) 
The incidence and severity of the complications increases with the difficulty of 
the intubation. Hematomas and lacerations can also be caused by the passage 
of the endotracheal tube through the vocal chords. 
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Methods 
 
An approval form the institutional Ethics Committee of the Hospital of S. João,  
Oporto, Portugal on September 29th 2011 was obtained as well as an informed 
written consent from American Society of Anesthesiologists (ASA) physical 
status I, II and III patients of both genders who were included in the present 
study. All patients were scheduled for elective surgery under general 
anaesthesia and with ages between 19 to 85 years old. The surgical procedures 
included in the study were general surgery, orthopedic, gynecological and 
vascular surgery. We gathered data from 48 patients, 26 underwent ETT (54%) 
and 22 LMA (46%). 
As this investigation was a non-randomized prospective study, the recruitment 
of patients did not interfere with the everyday routine so the medical and 
organization conditions remained unchanged. 
We recorded the patient´s age, sex, body mass index (BMI), and ASA physical 
status on a standardized information sheet (Table 1). The type and duration of 
surgery and operative airway management (ETT or LMA) were also recorded. 
Patients under 18 years old, with a recent history of sore throat, undergoing 
head and neck surgeries, presenting with preoperative dysphonia and 
emergency procedures were excluded from the study. 
Demographic characteristics such as age, sex, and BMI are similar between 
both groups.  
Duration of surgery was evaluated with the surgical time differing between the 
ETT and the LMA groups.  
The choice of airway access was decided by the anesthesiologist as well as the 
anesthetic agents used based on their assessment of the patient, personal 
preference, and experience with airway techniques.  A 6.5mm to 8mm ETT for 
woman and 7mm to 8mm for men were used in the ETT group. A size 3 or 4 
LMA were used for woman and size 4 or 5 were used for men, according to the 
patient´s weight. 
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In the Laryngoscope group a direct classic Macintosh laryngoscope was placed 
except in one patient who was intubated with a McCoy Laryngoscope.  
For the ETT group, the endotracheal tube was placed after laryngoscopy using 
standard techniques.  
In the LMA group, the cuff was inflated with air to ensure sealing of airway. 
Proper placement of the airway was confirmed by bilateral equal air entry on 
auscultation, normal rectangular shape capnograph tracing and visible chest 
rise. 
No constraint was placed on the technique of general anesthesia so that the 
anesthesiologists were free to perform the procedures as they intended to. 
Induction regimens varied widely according to anesthesiologist preference. The 
usual hypnotic anaesthetics were used. Rocuronium or Cisatracurium were 
used only in the ETT group to facilitate tracheal intubation. No muscle relaxants 
were used the LMA group.  
All patients were monitored using electrocardiography, pulse oximetry, non-
invasive blood pressure, end-tidal CO2 analysis and airway pressure. 
At the end of surgery the residual neuromuscular blockade was reversed with 
neostigmine and atropine when clinically necessary. 
Postoperative analgesic management was comparable in the two groups 
because the departments established routines were followed. All the patients 
systematically received the same protocol of postoperative analgesia, based on 
intravenous paracetamol (1g 8/8h) and parecoxib (40mg/day). In addition, when 
patients complained of pain [Visual Analogue Scale (VAS) >3/10 despite 
paracetamol and parecoxib administration], they received tramadol (100mg 
8/8h) or morphine (2mg ev every 10min, with a maximum dose of 6mg). 
After removal of the airway device in the operating room when patients were 
able to open their eyes to command, they were transferred to the post-
anesthesia care unit (PACU).  
In the recovery room, 4h to 24h after surgery, the oral cavity was inspected for 
any damage and pain in the lips, tongue and uvula. Oral opening width, 
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Mallampati classification, anatomical changes in the head and neck region as 
well as neck extension (normal or limited) and thyromental distance (Patil-
Aldreti test) were assessed. Patients were asked directly whether they had sore 
throat, and whether they had any dysphonia and dysphagia. Sore throat was 
defined as continuous throat pain regardeless swallowing, dysphonia was 
defined as impairment in the ability to produce vocal sounds and dysphagia was 
defined as any discomfort during swallowing. We evaluated laryngeal 
complaints with the following score: 0 - absent, 1 - present. If patients had pain 
we used a visual analogue scale (0 – no complaint, 10 – worst imaginable 
complaint). Dysphonia was also categorized as absent or present. The need of 
medication for pain relief was also recorded. 
The interview was carried out by the same person and always followed a 
standardized pattern. The incidence of laryngo-pharyngeal complaints was 
noted by using standardized direct questions. 
Statistical analysis was performed using SPSS statistics program version 
20.0.0. Normal distribution of samples was determined by the Kolmogoroff-
Smirnoff test. Significant differences of quantitative variables of independent 
samples were tested by Student´s t-test and Mann-Whitney test. Significant 
differences between groups for binomial variables were tested by Chi-Square 
test or Fisher´s exact test. In all cases, statistical significance was assumed to 
be p<0,05. 
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Results 
 
We analyze 48 patients: ETT was used in 54.2% and LMA in 45.8% patients. 
Four patients were excluded from the study, one patient refused to participate 
and another 3 were outside the inclusion criteria. Median age in both groups 
was 56.1±15.4 SD years and two thirds (66%) of the patients were female. 
There were no significant differences between the groups with respect to age, 
gender and BMI. Potential risk factors for difficult intubation such as Mallampati 
score, inter-incisor gap, neck circumference, head and neck flexion and 
extension, jaw configuration and thyromental distance were similar in both 
groups. (Table 2) 
Surgical procedure, ASA physical status and Mallampati classification differ 
between both groups, a lesser degree of ASA physical status was seen in the 
LMA group as well as a lower scoring Mallampati score (score I,II and only one 
patient III) in contrast with the ETT group. (Table 1) 
In our study, the overall incidence of postoperative sore throat was 23%, 
dysphonia 47.9% and dysphagia 12.5%. 
All 22 LMA insertions were performed by specialists, in the ETT group 6 
intubations were performed by interns and 18 by specialists.  
The mean duration of surgery was longer in the ETT group (120 min ±38.4 vs 
34 min ±15.8)(p<0.05). In our study, the duration of surgery, didn´t correlate 
with laryngeal complaints: sore throat (p=0.254), dysphagia (p=0.849), 
dysphonia (p=0.488) and tissue lesions (p=0.454). 
Of the 48 patients, 23% reported a sore throat. That was more frequent 
following ETT than following LMA (31% vs 14%, p=0.29). 
The average pain score, calculated from all 48 patients and expressed on a 
scale from 0 to 10 (Visual Analogue Scale=VAS), was 0.89 ±1.7. This very low 
result is misleading, as the data from the 37 who indicated no sore throat at all 
(value=0) has been included. Excluding value=0, the average pain score from 
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11 patients who indicated sore throat was 3.55±1.44. The severity of the 
individual complaints of laryngo-pharyngeal morbility, assessed on VAS, was 
comparable between groups. (Table 3) 
Surprisingly, dysphonia occurred more commonly in the LMA group than in the 
ETT group (50% vs. 46%, p=0.79). In all cases, except for one in the LMA 
group, dysphonia was considered by the patients to be mild. Only one patient in 
the LMA group reported severe dysphonia (aphonia) that was transitory and 
resolved spontaneously. 
The incidence of dysphagia was higher following ETT compared with LMA 
insertion (15.4% vs 9%, p=0.67). 
In our study we found a close relation between dysphagia and other laryngeal 
complaints. We witnessed that dysphagia complaints are always associated 
with sore throat (p=0,00) as well as dysphonia (p=0,01). No other relation 
between laryngeal complaints was found. 
Soft tissue trauma in lips, soft palate and uvula in the ETT group was seen in 
30.7% of cases and in 18.2% of cases in the LMA group (p=0.50). We did not 
detect any dental injury in any patient. 
We found a higher incidence of sore throat in women than in men (25% vs 
18.8%, p=0.73) although in our study, more men complained of dysphagia 
(18.8% male and 9.4% female, p=0.38) and of dysphonia in regards to women 
(56.2% vs 43.8%, p=0.61). 
The ETT group had more cases of sore throat, dysphagia and soft tissue 
trauma (lips, uvula, tongue or soft palate) than the LMA group. 
Merely assessing for sore throat, dysphonia and dysphagia, we found that the 
simultaneous occurrence of the three symptoms is higher in the ETT group than 
the LMA group (p=0.67) (Table 4) 
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Discussion 
 
The aim of this study was to assess which device, LMA or ETT, is most useful 
to reduce postoperative sore throat, dysphonia and dysphagia after general 
anesthesia, under clinical routine conditions. In our study, a standardized 
questionnaire was made face to face with the patients and direct questions 
were used. We compared demographic characteristics of the patients, as ASA 
score and surgical procedures. 
The LMA is positioned in the hypopharynx and the major advantages of this are 
its easy insertion, minimal contact with the vocal cords, absence of any residual 
discomfort and stress of laryngoscopy and avoiding muscle relaxants. Use of 
ETT requires administration of muscle relaxants for insertion and other agents 
for reversal of the effects of the latter. 
In our study, all patients subjected to ETT placement used neuromuscular 
blockade, showing evidence of a significantly lesser proportion of patients who 
had postoperative dysphonia in the group with the relaxant induction regimen 
(13). In the LMA group neuromuscular blockade wasn´t used in any patient. 
Complications secondary to endotracheal intubation include sore throat, 
dysphagia, dysphonia and trauma of the lips and oropharynx. The passing of 
the ET tube through the vocal chords can cause hematomas and lacerations, 
and visible laryngeal trauma occurs in 6% of cases due to endotracheal 
intubation, that was similar to what was found in our study.(14) 
Laryngeal morbidity may not only occur during intubation, but may also be the 
result of intraoperative factors. The literature describes that increasing duration 
of surgery led to an increased incidence of postoperative dysphonia, mainly 
because of mucosal damage caused by the endotracheal intubation, however, 
we found no relation between surgical time and the onset of laryngeal 
complaints.(5, 8) The baseline incidence of postoperative dysphonia has been 
reported to exist independently of the quality of tracheal intubation, which could 
explain why laryngeal damage could be observed in some patients despite 
optimal intubation conditions.(13) 
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Approximately 46% of ETT patients demonstrated dysphonia after surgery and 
this is comparable with previous findings. (5, 10)  However, dysphonia following 
surgery was also present in about 50% of LMA patients, something not found by 
others. (5, 8, 10, 11) Riger et al. found that in the LMA group complaints of 
dysphonia were less frequent, but dysphagia was more frequent. (5)  However, 
the study by Rieger et al, Figueiredo et al and Seung H et al and our study were 
of the few that assessed dysphonia after LMA placement. In our study the 
pressure cuff wasn´t measured and this could be an explanation of this findings. 
It is known from fiberoptic studies that direct contact of the LMA with the vocal 
cords and the arytenoid cartilage may occur, leading to airway complications 
like pharyngeal erythema, nerve palsies such as recurrent laryngeal, 
hypoglossal and lingual nerve with vocal cord palsy, arytenoid dislocation, 
epiglottitis, uvular bruising. (2, 6, 15) Vocal cord paralysis can also be 
associated with tracheal intubation. Direct trauma to the vocal cords by the LMA 
is uncommon, it is presumed that the cold and dry inhalation of anesthetic gas 
in positive pressure ventilation that passes over the vocal cords may 
substantially contribute to the transient impairment in vocal production following 
a LMA. (12) 
Postoperative sore throat complaints frequently arise after management of 
airway for general anesthesia, but they are of limited intensity as in our study, 
all patients complained of mild pain. (3) Our results concerning intensity of sore 
throat corresponded well with the results found in the literature. Sore throat is a 
common symptom and it can be attributed to ischemia-reperfusion injury, local 
inflammatory reaction, or abrasion.  
After endotracheal intubation, the incidence of sore throat varies from 14.4% to 
50% and after laryngeal mask insertion from 5.8% to 34%. (6) In our study,  the 
incidence of sore throat in the ETT group is approximately double that of sore 
throat in the LMA group (31% vs 14%), similar to what’s described in the 
literature. (1, 4, 11, 16) This finding is in contrast with the findings by Rieger A. 
et al that reports an incidence of sore throat that did not substantially differ 
between groups.(5) 
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Dysphagia is seen more often following ETT management than following LMA 
in our study, the presence of this complaint doesn´t deter from eating in any of 
the patients. 
Studies resorting to fibro-laryngoscopy have shown that abnormalities such as 
oedema and laryngeal ulcerations can by themselves compromise laryngo-
faryngeal sensibility and harm the airway protection mechanism during 
swallowing. (15) 
The higher the intubation difficulty is, the higher the incidence and severity of 
the following complications. Difficult intubation occurs in 1-18% of cases but, in 
our study no such case was reported. (17)  
In our study we compared several independent risk factors associated with 
difficult intubation such as Mallampati score, inter-incisor distance, 
thyromentonian distance, jaw configuration, head and neck flexion and neck 
circumference. We found no differences between both groups that would justify 
the higher reports of sore throat and dysphagia in the ETT group, because 
these characteristics were in the normal range. 
Many different variables can influence the incidence of the postoperative 
sequelae. Postoperative sore throat following anesthesia with LMA is 
multifactorial and its incidence can be influenced by the depth of anesthesia at 
the moment of insertion, the method of insertion, the number of attempts at 
placement, and also has been attributed to N2O diffusion through the cuff wall, 
cuff lubrication, and warming and humidifying anesthesia gases.(8) During 
anesthesia with the LMA, continuous cuff pressure increases can frequently be 
seen due to N2O diffusion in the cuff. The pressure exerted by the cuff against 
surrounding pharyngeal structures can exceed the capillary perfusion pressure 
and is seen as a decrease of pharyngeal perfusion.(2, 8, 18) However in our 
study, the cuff pressure wasn´t evaluated because the anesthesiologist was 
blind for the study and this parameter wasn´t taken into account. 
Many studies have identified several risk factors related with laryngeal mobility 
following ETT in which endotracheal size, cuff design, cuff pressure, use of 
N2O, demographic factors (woman), duration of anaesthesia, type of surgery 
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and quality of tracheal intubation and postoperative nausea and vomiting, 
general morbility of the patient, is also associated with technical difficulty. (3, 12, 
19) 
The laryngo-pharyngeal complaints after surgery such as sore throat and 
dysphagia could indicate bleeding, oedema, or more serious complications like 
perforation of the esophagus or trachea.(16) 
Our overall incidence of post-intubation laryngeal complaints for the LMA group 
was 55.5% and for the ETT group was 57.7%. 
Female patients had more sore throat complaints than male patients (25% vs 
19%), but lower dysphonia and dysphagia, and this could be explained by a 
smaller larynx.  
Although there is a chance for lower risk of airway complications when an LMA 
is used because its superior placement in the larynx could result in less irritation 
to the vocal cords and trachea, but surprisingly we found otherwise. Our study 
has demonstrated that using the LMA instead of the ETT leads to diminished 
postoperative sore throat and difficulty in swallowing, but an increase of hoarse 
voice. No patient required medication for laryngeal complaints. 
Limitations of our study were: a small sample size; underestimation of sore 
throat in both groups because the questionnaire was performed in the first 24 
hours after surgery, which could lead to lower incidence of this symptom since 
the patients are still under the effects of post-operative analgesia.  
We came to the conclusion that sore throat and dysphagia were more frequent 
after ETT. Dysphonia following LMA seems to be more frequent than previously 
reported. We described one case of LMA group with severe dysphonia 
(aphony). There were minimal differences between both groups, the advantage 
of the LMA vs ETT with regards to these parameters is questionable.  
In our study we found that all patients with dysphagia also had dysphonia and 
pain. We thus hypothesize that the presence of dysphonia could represent an 
aggression to the oesophageal mucosa and adjacent structures suggesting a 
more serious injury, although transitory and of self-resolution in nature. Thus, 
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we should expect to find in patients presenting with dysphagia associated 
simultaneous dysphonia and pain. Taking in to account that these last 
symptoms are more frequent, perhaps a lesser extent of injury is necessary 
during intubation to cause them. 
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Anexo 1 
TABLE 1                       Anthropometric and Peroperative Data 
 LMA group (n=22) ETT group (n=26) P – value* 
Age (years) 51,55±10,57SD 60,0±17.90SD 0.058 
Gender 
Female 
Male 
 
 
16 (72,7%) 
6 (27,3%) 
 
 
 
16 (61,5%) 
10 (38,5%) 
 
 
0.609 
BMI (Kg/m2) 28,1±4,9 29,4±7,3 0.535 
ASA physical 
status 
I 
II 
III 
 
11 (50%) 
9 (41%) 
2 (9%) 
 
0 (0%) 
22 (85%) 
4 (15%) 
0.00 
Mallampati 
I 
II 
III 
IV 
 
14 (63,6%) 
7 (31,8%) 
1 (5%) 
0 (0%) 
 
9 (34,6%) 
6 (23,1%) 
7 (27%) 
4 (15,4%) 
 
0.023 
Duration of 
Surgery (min) 
34±15,8 120±38,4 0.00 
Surgical 
procedure 
General Surgery 
Ginecological 
Orthopedic 
Vascular 
 
3 (13,6%) 
6 (27,3%) 
1 (5%) 
12 (55%) 
 
26 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
- 
*Statistical tests used: Chi-Square test, Mann Whitney test and Independent Sample T-test. 
BMI – Body Mass Index; ASA - American Society of Anesthesiologists 
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TABLE 2 
Potential Risk Factors for Difficult Intubation 
 
 
LMA group (n=22) ETT group (n=26) 
 
Inter-incision gap 
(cm) 
 
5.35±0.82 SD 5.95±0.91 SD 
Neck circumference 
(cm) 
 
 
39.55±3.36 SD 
 
 
 
42.20±5.64 SD 
 
 
Head and neck flexion 
 
>90° 
 
<90° 
 
 
 
22 (100%) 
 
0 (0%) 
 
 
22 (92.3%) 
 
2 (7.7%) 
 
 
Retrognathism 
 
Normal 
 
Prognathism 
 
 
1 (4.5%) 
 
20 (91%) 
 
1 (4.5%) 
 
0 (0%) 
 
26 (100%) 
 
0 (0%) 
 
 
Thyromental distance 
(cm) 
 
 
 
6.75±0.63 SD 
 
 
6.77±1.19 SD 
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TABLE 3 
Laryngeal Complaints 
 LMA group (n=22) ETT group (n=26) P – value 
 
Sore throat 
 
VAS* 
 
 
3 (14%) 
 
3,67±1.53 
 
8 (31%) 
 
3,5±1,51 
P = 0.288** 
Dysphonia 
 
 
11 (50%) 
 
 
 
 
12 (46%) 
 
 
P = 0,790** 
 
Dysphagia 
 
2 (9%) 4 (15,4%) P = 0,674*** 
 
Soft tissue trauma 
(lips or uvula or 
soft palate) 
 
4 (18,2%) 8 (30,7%) P = 0,503** 
 
*VAS – visual analogue scale 
** Chi-Square test 
*** Fisher´s Exact test 
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TABLE 4  
Number of Symptoms of Laryngo-pharyngeal complaints (Sore throat, 
dysphonia and dysphagia) in patients with LMA and ETT 
Number of 
symptoms* 
LMA group (n=22) ETT group (n=26) P – value** 
 
0 
 
10 (45.5%) 
 
11 (42.3%) 
 
P = 1.00 
1 
 
 
10 (45.5%) 
 
 
 
 
10 (38.5%) 
 
 
P = 0,770 
 
2 
 
0 (0%) 1 (3.8%) P = 1.00 
 
 
3 
 
 
2 (9.1%) 4 (15.4%) P = 0,674 
 
*Including dysphonia and/or dysphagia and/or sore throat. “0” symptoms mean that none of 
these three complaints are present. 
** Chi-Square Test and Fisher´s Exact Test. 
 
 
 
 
 
 
 
 
26 
 
Anexo 2 
Avaliação do dano orofaríngeo no pós-operatório 
 
1. Nº Processo:                                                                       Nº Codificador: 
 
2. Data do exame: ____ / ____ / ____ 
3. Sexo: 1- Masculino _____  2- Feminino  _____ 
4. Idade ____ anos 
 
5. Dor   1- Prévia   exclusão 
          2- Pós-op:  1) Sem dor ___ 
                             2) Gengiva/Mucosa (úvula/palato) ___ 
                             3) Odinofagia ___  Classificação VAS ___ 
 
6. Disfonia   1- Prévia  exclusão 
                     2- Pós-op: 1) Ligeira ___ 
                                      2) Grave ___                                              
7. Disfagia  1- Prévia  exclusão 
                    2 – Pós-op ___ 
8.  1- Peso ____ Kg;     2- Altura ____ m      3- IMC ____ 
9. Classificação de Mallampatti:   1- Grau I __  2- Grau II __  3- Grau III __  4- 
Grau IV __ 
10. Largura do pescoço: _____ cm 
11. Distância tiromentoneana: _____ cm 
12. Abertura máxima da boca: _____ cm 
13. Mobilidade do pescoço:  1- <90° ___   2- >90° ___  
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14. Configuração Mandibular:  1- Normal ___ 
                                                     2- Retrognatismo ___ 
                                                     3 - Prognatismo ___ 
15. Avaliação de lesões na úvula: 1- Presentes ___   2- Ausentes ___ 
 
Registos Anestésicos 
1. Tipo de Intubação: 
      1- Máscara Laringea ____ 
      2- Laringoscopia ____ 
         2.1 – Intubação Difícil:   1- Sim ___      2 - Não___  
         2.2 – Nº. de Tentativas da Intubação  ____ 
         2.3 – “Intubador”:  1- Especialista ____ 2- Interno ____ (ano de internato) 
         2.4 – Lâmina utilizada:1-McKintosh __ 2-Miller __ 3-MCCoy __ 4-Outro__ 
         2.5 – Intubação sob relaxamento muscular:    1- Sim ____    2- Não ____ 
 
2. Tempo da Cirurgia ________    
3. Classificação ASA 
        3.1 – I ___ 
        3.2 – II ___ 
        3.3 – III ___ 
        3.4 – IV ___ 
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4. Patologia Associada:    1 - Sim ____ Qual? ________________________ 
                                               2 - Não ____ 
 
5. Necessidade de analgesia no pós-operatório devido à presença de 
odinofagia/disfagia: 
       5.1 – Sim ____  Qual? _________________________________________ 
       5.2 – Não ____ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
Anexo 3 
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Eu, abaixo-assinado,______________________________________________ 
___________________________________________,declaro que compreendi 
a explicação que me foi fornecida acerca da investigação que se tenciona 
realizar, bem como do estudo em que serei incluído/a. Foi-me dada a 
oportunidade de fazer as perguntas que julguei necessárias, e de todas obtive 
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Além disso, foi-me afirmado que tenho o direito de recusar a todo o tempo a 
minha participação no estudo, sem que isso possa ter como efeito qualquer 
prejuízo na assistência que me é prestada. 
Por isso, estou interessado/a em participar no estudo. 
 
Data: _____ / ____________ / _____ 
 
Assinatura do doente_____________________________________________ 
 
Trabalho de Tese de Mestrado Integrado em Medicina por: 
Marta Sofia Penso de Barros 
Assinatura: 
_____________________________________________________________ 
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Mestre Joana Irene de Barros Mourão 
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Anexo 5 
Guidance for Authors on the Preparation and Submission of Manuscripts 
to the European Journal of Anaesthesiology 
Note: These instructions comply with those formulated by the International 
Committee of Medical Journal Editors (ICMJE). For further details, authors 
should consult the following article: International Committee of Medical Journal 
Editors. “Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals” New Engl J Med 1997, 336:309–315. The complete document 
appears at http://www.icmje.org. 
Scope 
The European Journal of Anaesthesiology (EJA) publishes original work of high 
scientific quality in the field of anaesthesiology, pain, emergency medicine and 
intensive care. Preference is given to experimental work or clinical observation 
in man, and to laboratory work of clinical relevance. The journal also publishes 
commissioned reviews by an authority, abstracts of scientific meetings, 
editorials, commentaries, special articles and correspondence are also 
included. 
Points to consider before submission 
We have prepared a standard covering letter to accompany your submission. 
Please complete and submit the letter with your manuscript. 
Redundant or duplicate publication  
We ask you to confirm that your paper has not been published in its current 
form or a substantially similar form (in print or electronically, including on a web 
site), that it has not been accepted for publication elsewhere, and that it is not 
under consideration by another publication. The ICMJE has provided details of 
what is and what is not duplicate or redundant publication. If you are in doubt 
(particularly in the case of material that you have posted on a web site), we ask 
you to proceed with your submission but to include a copy of the relevant 
previously published work or work under consideration by other journals. In the 
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standard covering letter to the editors, draw attention to any published work that 
concerns the same patients or subjects as the present paper. 
 
Conflicts of interest  
Authors must state all possible conflicts of interest in the manuscript, including 
financial, consultant, institutional and other relationships that might lead to bias 
or a conflict of interest. If there is no conflict of interest, this should also be 
explicitly stated as none declared. All sorces of funding should be 
acknowledged in the manuscript (see paragraph: Acknowledgements). 
Permissions to reproduce previously published material 
The EJA requires you to send us copies of permission to reproduce material 
(such as illustrations) from the copyright holder. Articles cannot be published 
without these permissions. 
Patient consent forms 
The protection of a patient's right to privacy is essential. Please send copies of 
patients’ consent forms on which patients or other subjects of your experiments 
clearly grant permission for the publication of photographs or other material that 
might identify them. If the consent form for your research did not specifically 
include this, please obtain it or remove the identifying material. 
A statement to the effect that such consent had been obtained must be included 
in the ‘Methods’ section of your paper and an example of the consent form you 
used must be uploaded with your manuscript. 
Ethics committee approval 
All articles dealing with original human or animal data must include a statement 
on ethics approval at the beginning of the Methods section. This paragraph 
must contain the following information: the name and address of the ethics 
committee responsible; the protocol number that was attributed by this ethics 
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committee; the name of the Chairperson of the ethics committee (or the person 
who approved the protocol) and the date of approval by the ethics committee. 
The paragraph could read, for example: 
Ethics: Ethical approval for this study (Ethical Committee N° NAC 207) was 
provided by the Ethical Committee NAC of Geneva University Hospitals, 
Geneva, Switzerland (Chairperson Prof N. Dupont) on 12 February 2007. 
In addition, for studies conducted on human participants you must state clearly 
that you obtained written informed consent from the study participants; please 
also look at the latest version of the Declaration of Helsinki. Similarly, for 
experiments involving animals you must state the care of animal and licensing 
guidelines under which the study was performed. If ethics clearance was not 
necessary, or if there was any deviation from these standard ethical requests, 
please state why it was not required. Please note that the editors may ask you 
to provide evidence of ethical approval. If you have approval from a National 
Drug Agency (or similar) please state this and provide details, this can be 
particularly useful when discussing the use of unlicensed drugs. 
Authorship  
We ask that all authors sign the standard covering letter. We ask all authors to 
confirm that they have read and approved the paper. Second, we ask all 
authors to confirm that they have met the criteria for authorship as established 
by the ICMJE, believe that the paper represents honest work, and are able to 
verify the validity of the results reported. 
All persons designated as authors should qualify for authorship and all those 
who qualify should be listed. Each author should have participated sufficiently in 
the work to take public responsibility for appropriate portions of the content. One 
or more authors should take responsibility for the integrity of the work as a 
whole, from inception to published article. Authorship credit should be based 
only on 1) substantial contributions to conception and design, or acquisition of 
data, or analysis and interpretation of data; 2) drafting the article or revising it 
critically for important intellectual content; 3) final approval of the version to be 
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published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the 
collection of data or general supervision of the research group, by themselves, 
do not justify authorship. All others who contributed to the work who are not 
authors should be named in the Acknowledgements section. 
Compliance with Research Funding Agency Accessibility Requirements 
A number of research funding agencies now require or request authors to 
submit the “post-print” (the final manuscript, in Word format, after peer-review 
and acceptance for publication but prior to the publisher’s copyediting, design, 
formatting, and other services) to a repository that is accessible online by all 
without charge. As a service to our authors, LWW will identify to the National 
Library of Medicine (NLM) articles that require deposit and will transmit the post-
print of an article based on research funded in whole or in part by the National 
Institutes of Health, Wellcome Trust, or the Howard Hughes Medical Institute to 
PubMed Central. Authors of research funded by other funding agencies may 
submit the post-print 12 months after publication of the final article, or 6 months 
after publication if the funding agency mandates a shorter time-frame. 
Copyright assignment  
Papers are accepted for publication on the understanding that exclusive 
copyright in the paper is assigned to the Publisher. Each author must complete 
and submit the journal’s copyright transfer agreement, which includes a section 
on the disclosure of potential conflicts of interest based on the 
recommendations of the ICMJE. The form is readily available on the manuscript 
submission page and can be completed and submitted electronically. Please 
note that authors may sign the copyright transfer agreement form electronically. 
For additional information about electronically signing this form , go 
to http://links.lww.con/ZUAT/A106. Without the signed copyright form, the 
manuscript cannot be published. 
Submissions  
All manuscripts and materials must be submitted through the web-based 
tracking system at https://www.editorialmanager.com/eja/. Submissions should 
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be in English, UK spelling is preferred. The standard covering letter should be 
included in the submission as a 'supporting document'. The site contains 
instructions and advice on how to use the system. Authors should NOT in 
addition then post a hard copy submission to the editorial office, unless you are 
supplying artwork, letters or files that cannot be submitted electronically, or 
have been instructed to do so by the editorial office. Include the following where 
appropriate: subject consent forms; transfer of copyright form; permission to 
reproduce previously published material; checklist. For those authors who have 
no option but to submit by mail please send one copy of the article, plus an 
electronic version on disk or CD-ROM to the following address: European 
Journal of Anaesthesiology, Editorial Office, Lippincott, Williams & Wilkins, 
250 Waterloo Road, London, SE1 8RD, UK. 
1.5 spacing should be used throughout the manuscript, which should include 
the following sections, each starting on a separate page: Title Page, Abstract 
and Keywords, Text, Acknowledgements, References, Tables and Figures, and 
captions. Margins should be not less than 3 cm. Pages should be numbered 
consecutively, beginning with the Title Page, and the page number should be 
placed in the top right hand corner of each page. Two letter abbreviations 
should be avoided. Longer abbreviations should be defined on their first 
appearance in the text; those not accepted by international bodies should be 
avoided. 
Presentation of papers 
Title Page 
The Title Page should carry the full title of the paper and a short title to be used 
as a ‘running head’ (and which should be so identified). Please, include the 
study design in the title; for instance, “randomized trial”, or “systematic review” 
(see EJA Editorial: How to write a good title). The first name, middle initial and 
last name of each author and their affiliations should appear. Academic degrees 
should not be stated. If the work is to be attributed to a department or institution, 
its full name should be included. The name and address of the corresponding 
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author and the name and address of the author to whom requests for reprints 
should be made should also appear on the Title Page. 
Structured Abstract 
For original articles (for systematic reviews and meta-analyses, see below), the 
second page should carry an abstract, which will be printed at the beginning of 
the paper and should not be more than 300 words. Use the following headings 
and information as appropriate (which are adapted from 
the BMJ and JAMA websites): 
Context: Explaining the clinical (or other) importance of the study question. 
Objective(s): Including a clear statement of the main aim(s) of the study and the 
major hypothesis tested or research question posed. 
Design: For example, randomised-controlled, case control, crossover, or 
observational study, survey, diagnostic test etc . 
Setting: Include the level of care e.g. primary, secondary; number of 
participating centres. Be general rather than give the name of the specific 
centre, but give the geographical location if this is important. Include the dates 
of the study period. 
Patients or other participants: Numbers entering and completing the study, sex, 
and ethnic group if appropriate. Give clear definitions of how selected, entry and 
exclusion criteria. For animal studies, this information should be included in the 
Design or Setting section. 
Intervention(s): What, how, when and for how long. This heading can be deleted 
if there were no interventions but should normally be included for randomised 
controlled trials, cross over trials, and before and after studies. 
Main outcome measures: Those planned in protocol, those finally measured (if 
different, explain why). 
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Results: Main results with (for quantitative studies) 95% confidence intervals 
and, where appropriate, the exact level of statistical significance. 
Conclusions: Primary conclusions and their implications, suggest areas for 
further research if appropriate. 
Trial registration: If appropriate, the trial registration should be stated at the 
end of the abstract, for example: “Trial registration: Clinicaltrials.gov identifier: 
NCT00405977.” 
The abstract should be usable as it stands by abstracting journals. Because of 
this it should contain some numerical data (if appropriate), not just statistical 
statements, and it should not contain abbreviations or references (see EJA 
Editorial: Writing the abstract: completeness and accuracy matter). 
For systematic reviews and meta-analyses, use the following headings and 
information: 
Context: 
Objective(s): 
Data sources: Where included studies were retrieved from? Include years 
searched. 
Eligibility criteria: Describe inclusion and non-inclusion criteria of selected 
studies. 
Results: 
Conclusions: 
 
Key Words 
The abstract should be followed by a list of 3–10 key words or short phrases 
which will assist the cross-indexing of the article. When possible, the terms 
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used should be from the Medical Subject Headings list of the National Library of 
Medicine. 
Text 
The remainder of the text should be divided into sections headed Introduction, 
Methods (including ethical and statistical information), Results, and Discussion 
(including a conclusion). 
Acknowledgements 
The acknowledgements section should contain two distinct statements: 
1. Assistance with the study. Acknowledgements should be made only to those 
who have made a substantial contribution to the study. Authors are responsible 
for obtaining written permission from people acknowledged by name in case 
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relevant conflicts of interest and sources of funding under a separate sub-
heading. If there are no conflicts of interest or sources of funding please state: 
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Number references consecutively in the order in which they are first mentioned 
in the text. Identify references in the text, tables and legends using 
superscripted Arabic numerals that are placed after the punctuation. 
References cited only in tables or in legends to figures should be numbered in 
accordance with the sequence established by the first identification in the text of 
the particular table or illustration. 
Use the Vancouver reference system as adopted by the U.S. National Library of 
Medicine ensuring that all journal titles conform to Index Medicus approved 
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photographs. Each table should have a brief title as a heading. Vertical rules 
should not be used. Place explanatory matter in footnotes, not in the heading. 
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Authors are discouraged from using abbreviations in tables. If abbreviations are 
necessary then please explain them in the table’s footnotes. Identify statistical 
measures of variations, such as standard deviation (SD) and standard error of 
the mean (SEM). 
Be sure that each table is cited in the text. If you use data from another 
published or unpublished source, obtain permission and acknowledge the 
source fully. 
Authors are encouraged to submit non-essential tables as supplemental digital 
content for publication online only. See Supplemental Digital Content section for 
more details. 
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References to figures should be made in order of appearance in the text and 
should be in Arabic numerals in parentheses, e.g. (Fig. 2). Most file formats are 
accepted, but TIFF and EPS files, with fonts embedded, are preferred. If 
scanned, line art should be at a resolution of 800 dpi, and halftones and colour 
at 300 dpi. All colour values should be CMYK. If hard copies are submitted they 
should have a label pasted to the back bearing the figure number, the title of the 
paper, the author’s name and a mark indicating the top of the figure. Figures 
should be presented to a width of 82 mm or, when the illustration demands it, to 
a width of 166 mm. Photomicrographs must have internal scale markers. If 
photographs of people are used, their identities must be obscured or the picture 
must be accompanied by written consent to use the photograph. If a figure has 
been published before, the original source must be acknowledged and written 
permission from the copyright holder for both print and electronic formats should 
be submitted with the material. Permission is required regardless of authorship 
or publisher, except for documents in the public domain. Figures may be 
reduced, cropped or deleted at the discretion of the editor. Colour figures are 
acceptable but authors will be expected to cover the extra reproduction costs, 
which amount to $1000 per article. 
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Figure legends 
Captions should be typed in 1.5 spacing, beginning on a separate page. Each 
figure should be assigned an Arabic numeral, e.g. (Figure 3) and a brief title as 
a heading. Internal scales should be explained and staining methods for 
photomicrographs should be identified. 
Units of measurement 
Scientific measurements should be given in SI units. Blood pressure, however, 
may be expressed in mmHg and haemoglobin as g dL-1. 
Abbreviations and symbols 
Authors are discouraged from using abbreviations. If an abbreviation is 
necessary please use only standard abbreviations. Avoid abbreviations in the 
title and abstract. The full term for which an abbreviation stands should precede 
its first use in the text unless it is a standard unit of measurement. 
Supplemental Digital Content 
Authors may submit supplemental digital content (SDC) to enhance their 
article’s text and to be considered for online-only posting. SDC may include the 
following types of content: text documents, graphs, tables, figures, graphics, 
illustrations, audio, and video. On the Attach Files page of the submission 
process, please select Supplemental Audio, Video, or Data for your uploaded 
file as the Submission Item. If an article with SDC is accepted, our production 
staff will create a URL with the SDC file. The URL will be placed in the call-out 
within the article. SDC files are not copy-edited by LWW staff, they will be 
presented digitally as submitted. For a list of all available file types and detailed 
instructions, please visit http://links.lww.com/A142. 
SDC Call-outs 
Supplemental Digital Content must be cited consecutively in the text of the 
submitted manuscript. Citations should include the type of material submitted 
(Audio, Figure, Table, etc.), be clearly labeled as "Supplemental Digital 
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Content," include the sequential list number, and provide a description of the 
supplemental content. All descriptive text should be included in the call-out as it 
will not appear elsewhere in the article.  
For example: We performed many tests on the degrees of flexibility in the elbow 
(see Video, Supplemental Digital Content 1, which demonstrates elbow 
flexibility) and found our results inconclusive. 
List of Supplemental Digital Content 
A listing of Supplemental Digital Content must be submitted at the end of the 
manuscript file. Include the SDC number and file type of the Supplemental 
Digital Content. This text will be removed by our production staff and not be 
published. 
For example: Supplemental Digital Content 1.wmv 
SDC File Requirements 
All acceptable file types are permissible up to 10 MBs. For audio or video files 
greater than 10 MBs, authors should first query the journal office for approval. 
For a list of all available file types and detailed instructions, please 
visit http://links.lww.com/A142. 
Reprints 
Reprints may be purchased using the appropriate form that will be made 
available with proofs. Orders should be sent when the proofs are returned; 
orders received after this time cannot be fulfilled. 
Article Types 
Randomised Controlled Trials  
Authors are requested to report these in accordance with the CONSORT 
(Consolidated Standards of Reporting Trials) statement [www.consort-
statement.org]. This ensures that enough information is provided for editors, 
peer reviewers, and readers to see how the study was performed and to judge 
whether the findings are likely to be reliable (see EJA Editorial: Adherence to 
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guidelines for improved quality of data reporting: where are we today?). Please 
provide the following: 
• A flow chart showing the progress of participants through the study  
• A checklist for editors and reviewers (not for publication) showing that 
you have described the recommended respective key points in your 
report. 
Maximum length of reports of randomised controlled trials is 3500 words. 
Please provide a structured abstract (max. 250 words). 
Systematic Reviews (with or without meta-analysis) 
Authors are requested to submit these as ‘Original articles’ (not ‘Reviews’) and 
report them in accordance with the PRISMA (Transparent Reporting of 
Systematic Reviews and Meta-Analyses) Statement [www.prisma-
statement.org]. This ensures that enough information is provided for editors, 
peer reviewers, and readers to see how the study was performed and to judge 
whether the findings are likely to be reliable (see EJA Editorial: Adherence to 
guidelines for improved quality of data reporting: where are we today?). Please 
provide the following: 
• A flow chart showing the progress of retrieved reports through the review 
• A checklist for editors and reviewers (not for publication) showing that 
you have described the recommended respective key points in your 
report. 
Maximum length of reports of systematic reviews is 3500 words. Please provide 
a structured abstract (max. 250 words). Authors are encouraged to publish 
additional material (for instance, large tables, figures with forest plots, data from 
subgroup analyses etc.) as Supplemental Digital Content (see above for 
details). 
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Conventional (non-systematic) Narrative Reviews 
There are three sources of narrative reviews – commissioned, non-
commissioned or invited, for instance, on the basis of a Refresher Course 
lecture presented at the annual Euroanaesthesia meeting. 
We welcome the submission of review articles and prospective authors are 
invited to contact the Editor-in-Chief to discuss their proposed topic. However, 
all review articles undergo peer review after submission and final acceptance is 
not guaranteed. 
Narrative reviews should start by posing a clear question they aim to answer or 
with a clear description of the intended educational aim. While such reviews do 
not include a systematic search, they should be compiled after a careful search 
of the available, recent literature taking care to avoid any personal bias. They 
should be based on the synthesis of statements that summarise the literature 
using appropriate references. Summary tables may be included and figures 
copied (with permission) from important papers in the field may help readers 
understand the subject matter. 
The manuscript should have a maximum length of 3500 words. Please include 
a title page (see paragraph: Title Page) and an acknowledgement statement 
(see paragraph: Acknowledgement). Please provide an unstructured abstract 
(maximum 350 words) which should summarise the most important 
conclusions. 
Practice Guidelines 
In general, published statements intended to guide clinical care (e.g., 
Guidelines, Practice Parameters, Recommendations, Consensus Statements, 
Position Papers) should describe: 
1. The clinical problem to be addressed; 
2. The mechanism by which the statement was generated; 
3. A review of the evidence for the statement (if available), and; 
4. The statement on practice itself. 
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As more than one group or society may issue statements on the same topic, 
this often results in confusion amongst clinicians. To minimize confusion and to 
enhance transparency, such statements should begin with the following bulleted 
phrases, followed by brief comments addressing each phrase: 
 What other guideline statements are available on this topic? 
 Why was this guideline developed? 
 How does this statement differ from existing guidelines? 
 Why does this statement differ from existing guidelines? 
Editorials 
Editorials discuss issues that are not directly related to published material. 
Editorials are usually commissioned. Editorials should be up to 1500 words long 
with no more than 15 references. Please include a title page giving all authors' 
names, addresses, email addresses, phone and fax numbers, as well as an 
Acknowledgement statement (see paragraph: Acknowledgements) and signed 
copyright forms. Editorials do not have an abstract. 
Commentaries 
Commentaries discuss issues that are directly related to published material. 
Commentaries accompany original articles, critically appraise their results and 
put their conclusions into a wider context. Commentaries are always 
commissioned and should be up to 1000 words long with no more than 10 
references. Commentaries do not have an abstract. Please include a title page 
giving the author's name, address, email address, phone and fax numbers, as 
well as an Acknowledgement statement (see paragraph: Acknowledgements) 
and signed copyright forms. 
Correspondence 
In this section, we publish case reports, letters and replies. Items in the 
Correspondence section are peer reviewed. Please look at a very recent copy 
of the European Journal of Anaesthesiology to see how the material should be 
presented. The format (layout) for the Correspondence section is quite different 
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from our other articles. The absolute maximum is 1000 words, which must 
include the space for any tables and illustrations (this is approximately two sides 
of printed matter in the Journal). References are limited to seven. For case 
reports please send copies of patient consent forms which clearly grant 
permission for the publication of photographs or other material that might 
identify the patient. A statement to the effect that such consent had been 
obtained must be included in your paper.  
 
The standard covering letter should be submitted with the correspondence. 
Correspondence articles do not have an abstract. Please include a title page 
giving the author's name, address, email address, phone and fax numbers, as 
well as an Acknowledgement statement (see paragraph: Acknowledgements) 
and signed copyright forms. 
English language editing  
If you are inexperienced in publishing medical articles in English then it may be 
helpful to have your manuscript reviewed by a professional editor so that you 
submit it in grammatically and syntactically acceptable English. The list below is 
provided for the benefit of authors seeking assistance in writing and editing their 
manuscripts. The EJA does not endorse any writing/editing services. 
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Apêndice 
COMPARAÇÃO DO DANO LARINGOFARÍNGEO 
TUBO OROTRAQUEAL VS MÁSCARA LARÍNGEA
M.Barros1, J. Mourão2.
1. Aluna da Faculdade de Medicina da Universidade do Porto
2.Assistente Hospitalar. Serviço de Anestesiologia, Centro Hospitalar S. João.; Faculdade de Medicina da Universidade do Porto.
DISCUSSÃO E CONCLUSÃO
A ET parece estar mais relacionada com dano laringofaringeo no que se refere à odinofagia, à disfagia e ao maior número de lesões dos 
tecidos moles comparativamente à utilização da ML. No nosso estudo encontramos uma associação entre disfonia e uso de ML 
superior à encontrada na literatura (2,3), assim como um caso de disfonia severa após a utilização da mesma técnica.
BIBLIOGRAFIA:
(1) El-Seify ZA, Khattab AM, Shaaban A, Radojevic D, Jankovic I. Low flow anesthesia: Efficacy and outcome of laryngeal mask airway versus pressure-optimized cuffed-endotracheal tube. Saudi journal of anaesthesia. 2010;4(1):6-10.
(2) Rieger A, Brunne B, Hass I, Brummer G, Spies C, Striebel HW, et al. Laryngo-pharyngeal complaints following laryngeal mask airway and endotracheal intubation. Journal of clinical anesthesia. 1997;9(1):42-7.
(3) Figueredo E, Vivar-Diago M, Munoz-Blanco F. Laryngo-pharyngeal complaints after use of the laryngeal mask airway. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1999;46(3):220-5.
INTRODUÇÃO E OBJECTIVOS:
A Máscara Laríngea (ML) constituí uma alternativa de manuseamento da via aérea relativamente à Entubação Orotraqueal (ET) para
procedimentos anestésicos. Complicações como odinofagia, disfonia e disfagia são sintomas frequentes após ET e a colocação da
ML.1Este estudo pretende comparar a incidência e a gravidade do dano laringofaringeo após a utilização da ET e ML.
MATERIAL E MÉTODOS:
 Estudo prospectivo não randomizado
 48 doentes entre os 19 e 85 anos, ASA I – III;
26 submetidos a ET (54%) e 22 a ML (46%).
 Cirurgia electiva sob anestesia geral – Cirurgia geral,
vascular, ortopédica e ginecológica.
 A escolha do acesso à via aérea assim como o
procedimento anestésico usados ficaram à
responsabilidade do anestesiologista (cego para o
estudo).
 Critérios de Exclusão:
 Doentes < 18 anos;
 Queixas prévias de odinofagia, disfagia e
disfonia;
 Cirurgia da cabeça e pescoço;
 Procedimentos de urgência.
 Os dados foram colhidos pela mesma pessoa usando um
questionário de perguntas directas, 4 a 24 horas após o
procedimento anestésico.
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